Association between fibroblast growth factor 23 and coronary artery calcification in patients with chronic kidney disease: a meta-analysis
Background Coronary artery calcification (CAC) is a common cardiovascular complication in patients with chronic kidney disease (CKD). Fibroblast growth factor 23 (FGF23), a key regulator of phosphate metabolism, has been implicated in vascular calcification, but studies evaluating its association with CAC in CKD have y...